aibioNNOX Nano-X Imaging Ltd.
Nano-X Imaging (NNOX) news
Nano-X Imaging Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NNOX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Nano-X Imaging news
We have not published a story on Nano-X Imaging yet. When there is news, it will appear here.
Nano-X Imaging annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $13.0 million | $11.3 million |
| Research and development | $19.2 million | $20.2 million |
| Net income (loss) | -$75.0 million | -$53.5 million |
| Cash from operations | -$40.8 million | -$36.6 million |
| Cash and equivalents | $49.2 million | $39.3 million |
| Short-term investments | $18.4 million |
Questions about Nano-X Imaging
What is the ticker symbol of Nano-X Imaging?
Nano-X Imaging Ltd. trades under the ticker NNOX on NASDAQ.
Where is Nano-X Imaging listed?
Nano-X Imaging Ltd. is listed on NASDAQ.
Which country or territory is Nano-X Imaging listed under?
Our directory records Nano-X Imaging Ltd. under United States.
Does aibio.space cover Nano-X Imaging?
aibio.space lists Nano-X Imaging Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Nano-X Imaging's revenue last year?
$13.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Nano-X Imaging profitable?
Nano-X Imaging Ltd. reported a net loss of $75.0 million for the fiscal year ended Dec 31, 2025, and used $40.8 million of cash in operations, per its annual report to the SEC.
How much does Nano-X Imaging spend on research and development?
$19.2 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Nano-X Imaging have?
$49.2 million in cash at Dec 31, 2025, per its 20-F.
Investor discussion: Nano-X Imaging
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a reverse stock split. SEC Form 6-K. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 6-K. Source
- Legal
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 6-K. Source
- Financings
Reported a financing. SEC Form 424B5. Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 6-K. Source
- Financings
Set up an at-the-market program to sell shares over time. SEC Form 424B5. Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 20-F. Source
Stock chart
Listing details
- Company
- Nano-X Imaging Ltd.
- Ticker
- NNOX
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction